SCHEMBL6725915

SCHEMBL6725915

O=S(=O)(Cc1ccc(-c2ncccc2-c2cccc(Br)c2)cc1F)Cc1ccc(-c2ncccc2-c2cccc(Br)c2)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 6/20 0.39
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
ALOX5AP P20292 4/20 0.36
KMO O15229 1/20 0.36
CDC25B P30305 1/20 0.36
MAOB P27338 1/20 0.35
BDKRB1 P46663 1/20 0.35
AKR1B1 P15121 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CHRM5 P08912 1/20 0.33
PADI1 Q9ULC6 1/20 0.33
PADI3 Q9ULW8 1/20 0.33
PADI4 Q9UM07 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6721925 0.91 CDC25B (0.38) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6722643 0.91 PTGS2 (0.41) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6730237 0.88 FEN1 (0.41) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6726013 0.87 FEN1 (0.38) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6718600 0.87 GLO1 (0.42) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6721604 0.87 PTGS2 (0.51) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6723029 0.86 PTGS2 (0.41) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6729798 0.86 KCNA5 (0.41) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6726098 0.84 PTGS2 (0.42) FEN1PTGS2PTGS1ALOX5APKMO
SCHEMBL6723308 0.84 KMO (0.39) FEN1PTGS2PTGS1ALOX5APKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 FEN1 1713/4885PTGS2 5/4885PTGS1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.